Combined Management of Severe Pseudomembranous Colitis: A Clinical Case Utilizing the ATLAS Scale
https://doi.org/10.31146/1682-8658-ecg-242-10-122-126
Abstract
Aim. To present clinical experience with combined management of severe pseudomembranous colitis using the ATLAS scale for risk stratification and therapeutic optimization. For patients scoring 4-6 points on the ATLAS scale, a diverting loop ileostomy is created with intraoperative catheter placement through the efferent limb into the colonic lumen. In the postoperative period, sequential antegrade colonic lavage is administered via the catheter according to the following protocol: vancomycin 125-250 mg, metronidazole 500-1000 mg, and fidaxomicin 200-220 mg in 500 mL of normal saline, followed by rebamipide 100-120 mg in 500 mL of normal saline - administered twice daily with a 6-hour interval for 10 days. Conclusion. The reported case demonstrates the effectiveness of this combined strategy for managing severe Clostridioides difficile-associated pseudomembranous colitis refractory to standard medical treatment.
About the Authors
G. A. Krotov
Moscow Clinical Scientific Center named after Loginov MHD
Russian Federation
Russian Federation
M. A. Danilov
Moscow Clinical Scientific Center named after Loginov MHD
Russian Federation
Russian Federation
O. V. Knyazev
Moscow Clinical Scientific Center named after Loginov MHD
Russian Federation
Russian Federation
V. V. Tsvirkun
Moscow Clinical Scientific Center named after Loginov MHD
Russian Federation
Russian Federation
A. V. Leontiev
Moscow Financial and Industrial University “Synergy”
Russian Federation
Russian Federation
A. E. Lychkova
Moscow Clinical Scientific Center named after Loginov MHD
Russian Federation
Russian Federation
References
1. Păduraru D.N., Ion D., Dumitrașcu M. et al. Clostridium difficile infection characteristics in a general surgery clinic. Experimental and Therapeutic Medicine. 2021 Aug 3;22(4). doi: 10.3892/etm.2021.10546.
2. Czepiel J., Dróżdż M., Pituch H. et al. Clostridium difficile infection: review. European Journal of Clinical Microbiology & Infectious Diseases. 2019 Apr 3;38(7):1211-21. doi: 10.1007/s10096-019-03539-6.
3. van Prehn J., Reigadas E., Vogelzang E.H. et al. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults. Clinical Microbiology and Infection. 2021 Dec;27: S1-21. doi: 10.1016/j.cmi.2021.09.038.
4. Neal M.D., Alverdy J.C., Hall D.E., Simmons R.L., Zuckerbraun B.S. Diverting Loop Ileostomy and Colonic Lavage. Annals of Surgery. 2011 Sep;254(3):423-9. doi: 10.1097/sla.0b013e31822ade48.
5. Bowman J.A., Utter G.H. Evolving Strategies to Manage Clostridium difficile Colitis. Journal of Gastrointestinal Surgery. 2020 Feb;24(2):484-91. doi: 10.1007/s11605-019-04478-5.
6. Miller M.A., Louie T., Mullane K. et al. Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy. BMC Infectious Diseases. 2013 Mar 25;13(1). doi: 10.1186/1471-2334-13-148.
7. Ahmad O., Crawford T.N., Arora V., Maskey M.K. Laboratory markers predictive of fulminant Clostridioides difficile infection refractory to fluid resuscitation. Infection Prevention in Practice. 2021 Jun;3(2):100127. doi: 10.1016/j.infpip.2021.100127.
Review
For citations:
Krotov G.A., Danilov M.A., Knyazev O.V., Tsvirkun V.V., Leontiev A.V., Lychkova A.E. Combined Management of Severe Pseudomembranous Colitis: A Clinical Case Utilizing the ATLAS Scale. Experimental and Clinical Gastroenterology. 2025;(10):122-126. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-242-10-122-126
Views:
6
JATS XML
Email this article 
